Save 10% off your first order | Limited time offer | Create your account now

Downloads

COA COO

Tofacitinib Impurity 151

Impurity

CAS Number

923036-25-3

Molecular Formula

C20H24ClN5

Product format

Neat

Molecular Weight

369.90

Shipping

Room Temperature

API Family

Tofacitinib

Synonyms

923036-25-3; N-((3R, 4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-amine; MFCD23160082; N-[(3R, 4R)-1-benzyl-4-methylpiperidin-3-yl]-2-chloro-N-methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-amine; C20H24ClN5; 2268720-86-9; Tofacitinib Impurity 31; 7H-Pyrrolo[2, 3-d]pyrimidin-4-amine, 2-chloro-N-methyl-N-[(3R, 4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-; SCHEMBL1374379; MXIDKFWWKNFJKE-PBHICJAKSA-N; DTXSID401335416; CS-M1986; AKOS027288964; CS-14432; N-(REL-(3R, 4R)-1-BENZYL-4-METHYLPIPERIDIN-3-YL)-2-CHLORO-N-METHYL-7H-PYRROLO[2, 3-D]PYRIMIDIN-4-AMINE; SY271335; NS00002078; E82876; F789450; N-((3R, 4R)-1-Benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2, 3-d]pyrimidin-4-amine;7H-Pyrrolo[2, 3-d]pyrimidin-4-amine, 2-chloro-N-methyl-N-[(3R, 4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]- (ACI); 2-Chloro-N-methyl-N-[(3R, 4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2 and 3-d]pyrimidin-4-amine (ACI)

Iupac Name

N-[(3R, 4R)-1-benzyl-4-methylpiperidin-3-yl]-2-chloro-N-methyl-7H-pyrrolo[2 and 3-d]pyrimidin-4-amine

InChI

InChI=1S/C20H24ClN5/c1-14-9-11-26(12-15-6-4-3-5-7-15)13-17(14)25(2)19-16-8-10-22-18(16)23-20(21)24-19/h3-8,10,14,17H,9,11-13H2,1-2H3,(H,22,23,24)/t14-,17+/m1/s1

Downloads

COA COO

Available products

Pack Size SKU
Category Expected Delivery Price Quantity

3-4 weeks

3-5 weeks

4-5 weeks

Request custom package size
Product added to your cart

Product Type

Custom
Synthesis

We offer tailor-made synthesis services of up to gram-quantities of materials for a wide range of pharmaceutical customers. The customer can order a specific molecule that is only synthesized on your request on the scale, with the purity and with the specification or methods you require.

Read more